A Three-mRNA Signature Associated with Pyrimidine Metabolism for Prognosis of BRCA.

Xiaoxue ZhangQiang ZhangXianxin XieYang LiZhiyuan PangTao Yu

Published in: BioMed research international (2022)

Our findings suggested that PyM-related mRNA signature might be a combined prognostic biomarker for BRCA and can provide important reference that are useful for individualized treatment for BRCA patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
breast cancer risk
prognostic factors
peritoneal dialysis
binding protein
patient reported outcomes